Viewing Study NCT00292461



Ignite Creation Date: 2024-05-05 @ 4:40 PM
Last Modification Date: 2024-10-26 @ 9:23 AM
Study NCT ID: NCT00292461
Status: COMPLETED
Last Update Posted: 2013-05-20
First Post: 2006-02-14

Brief Title: A Study for Evaluating the Efficacy and Safety of Zonisamide and Lamotrigine Lamictal for Subjects With Refractory Simple Partial Complex Partial or Partial With Secondary Generalized Seizures
Sponsor: Eisai Inc
Organization: Eisai Inc

Study Overview

Official Title: A Study for Evaluating the Efficacy and Safety of Zonisamide and Lamotrigine Lamictal for Subjects With Refractory Simple Partial Complex Partial or Partial With Secondary Generalized Seizures
Status: COMPLETED
Status Verified Date: 2009-08
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The purpose of this study is to evaluate the efficacy and safety of zonisamide for anti-epilepsy drugs AEDs treated subjects with refractory simple partial complex partial or partial with secondary generalized seizures
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None